Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

(University at Buffalo) A majority of patients with type 1 diabetes who were treated with dapagliflozin, a type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news